Indriķis
Liepa
Partner / Latvia
 
about

Indriķis Liepa heads IP, IT and Regulatory practice group and is among the leading practitioners in pharmacy law. He has a vast track record of over 15 years in consulting the leading local and foreign financial, food production, IT and other companies. Indriķis has substantial skills base in arranging major local M&A deals and significant investment projects.

Indriķis has extensive knowledge on pharmacy law and is rendering both - daily legal support to numerous pharmacy undertakings and has also advised on major pharmaceutical industry headline deals.

 
recognition
  • Corporate/Commercial - Band 4, Chambers Global and Europe 2022
  • Leading Trademark Professional - Bronze band, World Trademark Review 1000 2022
 
cv
Languages
  • Latvian, English, Russian


Membership & education
  • Latvian Bar Association (since 2002)
  • Institute for Corporate Sustainability and Responsibility
  • International Association of Young Lawyers
  • Master’s degree in Law, Riga Graduate School of Law, Riga, Latvia (2003)
  • Lawyer’s qualification,  University of Latvia, Riga, Latvia (2002)


Publications
Load More
 
experience
Load More
  • 2015 — 08 — 03
    COBALT represents Konekesko Latvija in tax dispute with the State Revenue Service
  • 2015 — 07 — 17
    Tax advice to Octapharma Nordic AB
  • 2015 — 04 — 24
    COBALT represents Tavex, the largest investment gold dealer in Northern Europe
  • 2015 — 04 — 14
    Representation of Abbott Laboratories Baltics
  • 2015 — 03 — 18
    COBALT advises H&M on Latvian tax matters
  • 2015 — 03 — 10
    General legal assistance to Mylan
  • 2015 — 03 — 04
    Legal assistance to Nordic Sugar AS
  • 2015 — 02 — 27
    General legal assistance to GlaxoSmithKline
  • 2015 — 02 — 11
    COBALT advises Abbott Laboratories on sale to Mylan of non-U.S. developed markets specialty and branded generics business
  • 2015 — 02 — 05
    General legal assistance to Roche
  • 2015 — 01 — 28
    COBALT advises Association of Biopharmaceutical Medicinal Products in Latvia (includes AbbVie, Merck Serono, Roche and others) on amendments to legal pharma-regulations
  • 2015 — 01 — 22
    General legal assistance to Abbott Laboratories
  • 2015 — 01 — 08
    General legal assistance to Abbvie
  • 2014 — 11 — 21
    COBALT advises Franklin Templeton Investments in acquisition of majority stake in SIA Storent Holding
  • 2014 — 10 — 30
    COBALT advises Merck & Co., Inc in sale of Merck’s consumer care business
  • 2014 — 08 — 28
    COBALT represents minority shareholder interests in acquisition of 60% stake in Ask.fm by Dutch company IAC Search Europe B.V.
  • 2014 — 08 — 04
    Legal advice to Roche Latvia on implementation of a distribution scheme
  • 2014 — 06 — 09
    COBALT provides legal assistance to SIA FMS on company sale to major North European IT company Visma Group
  • 2014 — 03 — 28
    COBALT advises Wikimedia on Latvian tax matters
  • 2014 — 03 — 06
    Tax advice to Homburg Invest Inc. in global corporate restructuring process
  • 2014 — 03 — 04
    COBALT advises Canadian stock listed company within implementation of a restructuring plan governed under Canadian CCAA rules in the Baltics
  • 2013 — 11 — 15
    COBALT advises Association for Lymphoma Patients’ Support and the Rare Disease Association Caladrius
  • Indrikis Liepa has a clear vision, the ability to explain legal issues in business language and good project management skills. He is flexible and responsive.
    LEGAL 500 2020, COMMERCIAL, CORPORATE AND M&A